Novo Nordisk nach Split WKN: A3EU6F ISIN: DK0062498333 Kürzel: NOV Forum: Aktien User: Coronaprofiteur
Diese Werbung richtet sich nur an Personen mit Wohn-/Geschäftssitz in Deutschland. Der jeweilige Basisprospekt, etwaige Nachträge, die Endgültigen Bedingungen sowie das maßgebliche Basisinformationsblatt sind auf www.dzbank-wertpapiere.de veröffentlicht. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.
Orfoglipron (Foundayo) label shortcomings Just looked into the PI (label) of Foundayo (Orfoglipron) We all knew that the efficacy will not be has high as injecatables or Wegovy Pill and it will most likely be somewhat less tolerable But I am really surprised about some of the other things that are on the label: There is reference to DDI with Simvastatin - this is a big problem for many as so many people on AOM also use Statins. I remember Novo CEO made a reference to this at JPM congress back in January and Dave Ricks said it’s a non-issue , well it happens to be in the label now. There is also a warning for Women who are on birth control pills (contraceptives) as they have to stop 30 days before starting the Orfo medication- this is also a major issue as many patients are women and will not want to chose between their birth control pill and their anti obesity medication. And to top it all off, unusually there is specific issue with Foundayo and hair loss !
Orfoglipron (Foundayo) label shortcomings Just looked into the PI (label) of Foundayo (Orfoglipron) We all knew that the efficacy will not be has high as injecatables or Wegovy Pill and it will most likely be somewhat less tolerable But I am really surprised about some of the other things that are on the label: There is reference to DDI with Simvastatin - this is a big problem for many as so many people on AOM also use Statins. I remember Novo CEO made a reference to this at JPM congress back in January and Dave Ricks said it’s a non-issue , well it happens to be in the label now. There is also a warning for Women who are on birth control pills (contraceptives) as they have to stop 30 days before starting the Orfo medication- this is also a major issue as many patients are women and will not want to chose between their birth control pill and their anti obesity medication. And to top it all off, unusually there is specific issue with Foundayo and hair loss !
Mehr zu diesem Wert
|
|
Thema | ||
|---|---|---|---|
| 1 | Novo Nordisk nach Split | ||
| 2 | Novo Nordisk |
|
|
Thema | ||
|---|---|---|---|
| 1 | DAX / Germany 40 Hauptdiskussion | +0,87 % | |
| 2 | ORACLE Hauptdiskussion | -3,54 % | |
| 3 | RHEINMETALL Hauptdiskussion | -1,93 % | |
| 4 | DAX Prognose / Germany 40 | +0,87 % | |
| 5 | Linien und Wellen Austausch Forum | +0,74 % | |
| 6 | NEL ASA Hauptdiskussion | -0,26 % | |
| 7 | Trading- und Aktien-Chat | ||
| 8 | ATOS Hauptdiskussion | -0,52 % | |
| 9 | MICRON TECHNOLOGY Hauptdiskussion | +0,37 % | |
| 10 | DPCM Capital Hauptdiskussion | +0,80 % | Alle Diskussionen |
|
|
Thema | ||
|---|---|---|---|
| 1 | ORACLE Hauptdiskussion | +2,38 % | |
| 2 | RHEINMETALL Hauptdiskussion | -2,02 % | |
| 3 | Linien und Wellen Austausch Forum | +0,59 % | |
| 4 | NEL ASA Hauptdiskussion | -0,05 % | |
| 5 | ATOS Hauptdiskussion | -0,52 % | |
| 6 | EVOTEC Hauptdiskussion | -2,48 % | |
| 7 | MICRON TECHNOLOGY Hauptdiskussion | +0,36 % | |
| 8 | DPCM Capital Hauptdiskussion | -0,35 % | |
| 9 | Gossamer Bio Hauptforum | -10,83 % | |
| 10 | SAP Hauptdiskussion | +0,61 % | Alle Diskussionen |